Glaxo Wellcome Production, FRANCE
- B01 - Agentes antitrombóticos
- ARIXTRA solution for injection 2.5 mg/0.5 ml
- FRAXIPARINE solution for injection 1 900 IU Anti-Xa/0.2 ml
- FRAXIPARINE solution for injection 2 850 IU Anti-Xa/0.3 ml
- FRAXIPARINE solution for injection 3 800 IU Anti-Xa/0.4 ml
- FRAXIPARINE solution for injection 5 700 IU Anti-Xa/0.6 ml
- FRAXIPARINE solution for injection 7 600 IU Anti-Xa/0.8 ml
- FRAXIPARINE solution for injection 9 500 IU Anti-Xa/1 ml
- N02 - Analgésicos
- PANADOL suppository 125 mg
- PANADOL suppository 250 mg
- P02 - Antihelmínticos
- ZENTEL film-coated tablet 200 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- BECLOFORTE pressurised inhalation, suspension 250 µg/dose
- BECOTIDE pressurised inhalation, suspension 50 µg/dose
- FLIXOTIDE EVOHALER pressurised inhalation, suspension 125 µg/dose
- FLIXOTIDE EVOHALER pressurised inhalation, suspension 250 µg/dose
- FLIXOTIDE EVOHALER pressurised inhalation, suspension 50 µg/dose
- SEREVENT pressurised inhalation, suspension 25 µg/dose
- VENTOLIN D inhalation powder, pre-dispensed 200 µg
- VENTOLIN EVOHALER pressurised inhalation, suspension 100 µg/dose
- VENTOLIN syrup 2 mg/5 ml